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PEX13f the components of a peroxisomal membrane complex involved in import of
proteins into the matrix of the organelles and has previously been characterized in a variety of organisms.
Trypanosomatids (Trypanosoma, Leishmania), protozoan parasites having peroxisome-like organelles
designated glycosomes, possess an unusual PEX13 which shares very low sequence identity with others
and lacks some typical PEX13 characteristics. It was identiﬁed in the databases through its multiple YGx
motifs present in a glycine-rich N-terminal region of low sequence complexity. Like other PEX13s, it contains
predicted transmembrane segments and a SH3 domain in its C-terminal half. The localization of T. brucei
PEX13 in the glycosomal membrane was conﬁrmed by expression of a fusion construct with Green
Fluorescent Protein, and western blot analysis of puriﬁed organelles and membranes. The C-terminal half of
the protein was shown to interact with the third of three pentapeptide repeats of the previously
characterized PEX5, the receptor of glycosomal proteins with a type 1 peroxisome-targeting signal, and with
PEX14, another component of the same peroxisomal protein import complex in the membrane. PEX13 is
essential for the parasite; depletion by RNA interference results in mislocalization of glycosomal proteins and
death of the parasites.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionOrganisms belonging to the protozoan order Kinetoplastida
possess multiple copies of a unique organelle called the glycosome.
It belongs to the peroxisome family of organelles [2–5]. Like
peroxisomes from mammals, plants and yeasts, it harbours enzymes
of fatty-acid β-oxidation and ether-lipid biosynthesis. The main
characteristic of glycosomes is, however, the presence of the ﬁrst
seven enzymes of the glycolytic pathway, whereas the last part of the
pathway is present in the cytosol [6]. Glycosomes are also distin-
guished by the presence of enzymes of the gluconeogenic and
pentose-phosphate pathways, and enzymes responsible for pyrimi-
dine biosynthesis and purine salvage [3,5].
The compartmentation of the glycolytic enzymes has been studied
in most detail in Trypanosoma brucei, that often serves as a model
organism of the Kinetoplastida and is responsible for African sleeping
sickness. Trypanosomes reside in the blood of infected people and
variousmammals and are transmitted between them by tsetse ﬂies. Inabbreviations of proteins and
ycosomes in mammals, yeasts
nsus nomenclature system for
ized upper case for genes) [1].
2 7626853.
ichels).
l rights reserved.the bloodstream form of this parasite more than 90% of the protein
content of glycosomes consists of glycolytic enzymes. This compart-
mentation is essential; a slight mislocalization of at least some of
these enzymes to the cytosol results in death of the parasite [7–11].
This relates to the fact that glycolysis is the only source of ATP for
trypanosomes living in the blood and even slight relocation of
enzymes may interfere with correct functioning of the pathway. The
metabolic processes of the mitochondrion are almost completely
repressed during this stage of the life-cycle. In contrast, cultured so-
called procyclic stage cells, representative of T. brucei living in the
insect midgut, rely for their ATP supply largely on mitochondrial
catabolism of amino acids and express the enzymes of the tricar-
boxylic acid cycle and oxidative phosphorylation [5,12]. For the
reasons stated above, glycolysis and the biogenesis of the glycosome
have been proposed as promising targets for the discovery of badly-
needed drugs against sleeping sickness and other tropical diseases
caused by kinetoplastid parasites [13–16].
Like peroxisomes, glycosomes are single membrane bounded
organelles that do not contain DNA. Glycosomal matrix proteins,
such as glycolytic enzymes, are encoded by nuclear genes, synthe-
sized in the cytosol and imported post-translationally. Peroxisome
and glycosome biogenesis occurs by processes that have been
characterized mainly in yeasts (Saccharomyces cerevisiae, Pichia
pastoris, Hansenula polymorpha, Yarrowia lipolytica) and humans,
but also in other mammals, plants, the nematode Caenorhabditis
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peroxins (abbreviated as PEX), involved in different steps of the
biogenesis of the organelle, its division and segregation, have been
identiﬁed among these organisms. The sequences of the peroxins are
poorly conserved between organisms and for some proteins it has
even been impossible to ﬁnd homologues in distantly related
organisms. Nevertheless, the overall process has been conserved
throughout eukaryotic evolution.
One aspect of the biogenesis of peroxisomes and glycosomes
concerns the uptake of matrix proteins. This process comprises several
distinct consecutive steps. In the ﬁrst step, a cytosolic receptor, PEX5
or PEX7, recognizes the matrix protein to be imported, recognition
being dependent on the latter's peroxisome-targeting signal, PTS1 or
PTS2, respectively. PTS1 is a C-terminal tripeptide with the consensus
sequence –(S/C/A),(K/R/H),(L/M), but some upstream residues may
also affect the efﬁciency of import [20]. The consensus sequence of
PTS2, a nonapeptide located close to the N-terminus, is –(R/K),(L/V/I),
X5,(H/Q),(L/A)– where X is any residue [21]. A few proteins that have
neither a PTS1 nor a PTS2, possess a non-consensus, sequence-internal
peroxisome-targeting signal (I-PTS). The way these proteins are
translocated across the membrane is unknown. A ‘piggy back’ model
has been proposed wherein the I-PTS protein interacts with a PTS1- or
PTS2-containing protein to be imported. This ﬁts with observations
that folded and even oligomeric proteins can enter the organelle [22].
However a strong case has been made for the notion that sorting of I-
PTS proteins also involves direct binding to PEX5 [23].
PEX5 belongs to the tetratricopeptide repeat protein (TPR) family.
Its C-terminal domain, that contains seven such repeats, is responsible
for the interactionwith the PTS1, whereas its N-terminal half interacts
with various other peroxins [24–26]. PEX7 belongs to the WD40
repeat protein family, but little information is available as yet how it
recognizes PTS2 and binds to other proteins involved in the biogenesis
of the organelle [21].
As a second step, the receptor PEX5 or PEX7 with its cargo bound,
associates with the organelle through interaction with a docking
complex present in themembrane. This complex comprises minimally
PEX13 and PEX14, whereas in yeasts alone it also contains a PEX17
[17,27,28]. The docking leads to the translocation of the cargo into the
lumen of the peroxisome. This step is as yet poorly characterized. A
hypothesis is that the docking triggers a conformational change in
PEX5, allowing it to insert as an oligomer into the membrane thereby
forming a pore and releasing the cargo at the luminal face [29]. For
PEX7, however, experimental data indicate that it enters completely,
with its cargo, into the organelle's matrix [30].
After release of their cargo, the receptors are recycled back to the
cytosol through the action of a complex of two cytosolic AAA-ATPases,
PEX1 and PEX6, which transiently bind to the membrane protein
PEX15 in yeasts or PEX26 in mammals [18,19,31,32]. The cytosolic
PEX4, anchored to the membrane via PEX22, is also involved in this
recycling of PEX5. In yeast and human cells it has been shown that
PEX5 recycling is regulated by ubiquitination of the receptor and
PEX4, belonging to the family of E2 ubiquitin-conjugating enzymes,
is involved in this process [33–35]. Finally, a complex composed of
three RING ﬁnger proteins (PEX2, PEX10, PEX12) present in the
membrane, is proposed to be involved in the translocation of the
receptors and/or, through a RING-ﬁnger associated E3-ubiquitin-
ligase activity, in the delivery of the receptors, released from their
cargo, to the recycling machinery.
PEX13, partner of PEX14 in the docking complex in the membrane,
has been identiﬁed in various yeasts, mammals and very recently also
in plants [27,36,37]. Mutant analysis has shown that it is an essential
component of both the PTS1 and PTS2 import pathways. It is an
integral peroxisomal membrane protein with two transmembrane
segments and a C-terminal Src-homology 3 (SH3) domain exposed to
the cytosol. Such domains are known to be involved in a wide variety
of protein–protein interactions, for example in signal transduction andprotein localization. In both yeasts andmammals PEX13 interacts with
the PTS1 receptor PEX5 and its docking complex partner PEX14, but
the nature of the binding sites is not identical in the different
organisms. Moreover, PEX13 binding, through its N-terminal part, to
the PTS2 receptor PEX7 has been demonstrated in yeasts, mammalian
and plant cells [36,38,39]. The SH3 domain of S. cerevisiae PEX13
interacts with one of the characteristic pentapeptide motifs
(WXXXW/F) in the N-terminal half of PEX5 and with a PXXP-motif
of PEX14 [28]. The interaction with PEX14 also involves, in this
organism, a second site located between the two transmembrane
regions of PEX13 [40]. In contrast, in human PEX13 it is the N-terminal
part, not the SH3 domain, that interacts with PEX5 [38], while the SH3
domain binds to a conserved N-terminal region of PEX14 [41].
T. brucei homologues of several peroxins functioning in the
import of peroxisomal matrix proteins have been identiﬁed
previously and shown to be involved in glycosome biogenesis.
These peroxins include the receptors PEX5 and 7, the docking
complex protein PEX14, the RING ﬁnger proteins PEX2, 10 and 12
and the AAA-ATPases PEX1 and 6 (reviewed by [15]). Interestingly,
all these T. brucei peroxins display low sequence similarity with their
mammalian counterparts and, for most of them, RNA interference
has demonstrated that they are essential for the viability of the
trypanosomes. Therefore, these proteins are considered promising
targets for the discovery of anti-trypanosome drugs. Previous
searches and biochemical efforts to identify in trypanosomes the
important docking complex protein PEX13, or a non-homologous
protein with similar function, were unsuccessful. However, in this
paper we conﬁrm the existence of a trypanosome PEX13 with similar
functions as the homologous peroxins in other eukaryotes, but with
a rather different primary structure.
2. Materials and methods
2.1. Trypanosomes, growth conditions and transfection
Bloodstream and procyclic forms of T. brucei 427, cell line 449 [42],
that were used in this study, constitutively express the Escherichia coli
tetracycline (Tet) repressor gene from the chromosomally integrated
plasmid pHD449, also endowing phleomycin resistance. This cell line
is metabolically indistinguishable from the wild type. Bloodstream
forms were cultured in HMI-9 medium containing 10% heat-
inactivated foetal calf serum (Invitrogen) and 0.18 μg·mL−1 phleomy-
cin (Cayla) at 37 °C under water-saturated air with 5% CO2. Procyclic
trypanosomes were grown in SDM-79 medium [43] supplemented
with 15% foetal calf serum and 0.5 μg·mL−1 phleomycin at 28 °C under
water-saturated air with 5% CO2. Cultures were always harvested in
the exponential growth phase, i.e., at densities lower than 2·106
cells·mL−1 for bloodstream forms and 2 ·107 cells·mL−1 for procyclic
cells, by centrifugation at 1000 ×g for 10 min.
Transfection of both forms of trypanosomes, and selection of
clones were performed as described previously [10,44]. After
transfection and selection, positive clones were stored at −80 °C in
appropriate medium containing 12% glycerol.
2.2. Database searches and sequence alignment
Database searches were carried out with BLAST and PSI-BLAST
[45]. Motif searches were carried out using the ps_scan program [46]
in the Leishmania major genome [47]. Candidates were analyzed for
the presence of recognizable domains by scanning against the CDD
database using RPS-BLAST [48] or HHpred [49]. Fold recognition
studies were done at the META server [50] which also reports a
secondary structure prediction obtained using PSI-PRED [51]. Trans-
membrane helices were sought using several online methods —
TMHMM [52], DAS [53], HMMTOP [54], SOSUI [55] and TMPRED [56].
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Jalview [58].
2.3. Subcellular fractionation of T. brucei. Preparation of membrane
extracts
Wild-type bloodstream and procyclic cells (3 ·1010 and 6·109,
respectively) were collected, centrifuged for 20 min at 1000 ×g and
washed in isotonic SIE buffer (250 mM sucrose, 3 mM imidazole–HCl,
pH 7.0, 1 mM EGTA). Cells were homogenized (microscopically
checked) in a mortar with carborundum powder as described
previously [59]. Differential centrifugation [60] was performed as
follows: the suspension was taken up in another 4 (bloodstream
forms) or 5 (procyclics) mL SIE buffer and centrifuged at 30 ×g for
3 min. The pellet was washed twice with 1 or 2.5 mL of SIE buffer and
then discarded, whereas the pooled supernatants, representing the
cell homogenate, were centrifuged at 1500 ×g for 10 min giving the
nuclear fraction. The post-nuclear supernatant was then centrifuged
at 5000 ×g for 10 min giving the large-granular (mitochondria-
enriched) fraction as pellet. In order to obtain the small-granular
(glycosomes-enriched) fraction, the supernatant was then centrifuged
at 15,000 ×g for 30 or 10min. A further centrifugation step (140,000 ×g
for 1 h) gave the microsomal fraction and the cytosol depleted of all
the organelles. Different amounts of proteins representing 3.0 or 3.42%
of each fraction/sample's volume from bloodstream and procyclic
cells, respectively, were then subjected to SDS/PAGE. In the case of the
total cell homogenate and cytosolic fraction, each having a large
volume, proteins were ﬁrst concentrated by precipitation with ﬁve
volumes methanol/chloroform (4/1 v/v) following the protocol
described by Wessel and Flügge [61]. After size-fractionation, the
proteins were blotted onto nitrocellulose membranes and probed
with antisera raised against PEX13, PEX11 as glycosomal membrane
control, pyruvate kinase (PYK) or enolase (ENO) as cytosolic controls
and glyceraldehyde-phosphate dehydrogenase (GAPDH), aldolase
(ALD) and/or triosephosphate isomerase (TIM) as glycosomal matrix
protein controls.
A glycosomal membrane extract was prepared as follows: 100 μg
and 25 μg of glycosomes-enriched fractions from respectively blood-
stream and procyclic cells were incubatedwith the detergent digitonin
at a ﬁnal concentration of 1 mg·(mg protein)−1. The volume of the
samples was adjusted to 100 μl with SIE buffer. Samples were
incubated for 15 min on a rotating wheel at ambient temperature
followed by 1 h on ice and subsequent centrifugation for 20 min at
15,000 ×g. After removal of the supernatant (glycosomal matrix
content) the pelletwaswashedwith SIE buffer. Glycosomalmembrane
andmatrix sampleswere then extracted andprecipitated by treatment
with methanol/chloroform. The concentrated samples thus obtained
were size-fractionated by SDS/PAGE, transferred to a nitrocellulose
membrane and probed with anti-PEX13 and anti-PEX11 antisera.
Immunoprobing of western blots prepared with a Hybond
nitrocellulose membrane (Amersham Biosciences) was performed
according to a standard procedure [62]. For detection of the proteins,
rabbit polyclonal antisera raised against T. brucei PEX13 (antiserum at
a dilution 1:20,000), PEX11 (1:4000), ENO (1:10,000), PYK
(1:100,000), GAPDH (1:100,000), ALD (1:150,000), TIM (1:5000)
and glycerol kinase (GK, 1:100,000) were used. The secondary
antibodies, anti-(rabbit IgG) conjugated to horseradish peroxidase
(Rockland Immunochemicals) were diluted 1:15,000 fold and visua-
lized with the ECL Western Blotting System, a luminol-based system
(Pierce), in conjunction with exposure of an autoradiographic ﬁlm by
the blot.
2.4. Molecular biology methods
For most experiments in molecular biology standard methodolo-
gies were used [63] or protocols were followed as provided bysuppliers of enzymes used for various forms of DNA and RNA
manipulation (Fermentas, Roche Applied Science, New England
Biolabs, Promega, Invitrogen, TaKaRa, Novagen). E. coli strain XL-1-
Blue (Stratagene) was used for all plasmid cloning.
2.5. Construction of a GFP-tagged version of PEX13 and
immunoﬂuorescence studies
In order to express in trypanosomes a PEX13 fused to the C-
terminal side of Green Fluorescent Protein (GFP), full-length T. brucei
PEX13 was ampliﬁed by PCR using Pfu DNA polymerase (Fermentas)
and the following primers: 5′-ATAAGCTTTAATGTACGGTGGT-
TATGGTG-3′ (forward) and 5′-ATGGATCCCTAGAGTTTTGTCTCCCTC-3′
(reverse). The forward primer containing a HindIII site (underlined)
corresponds to the 5′ end of the PEX13 gene and the reverse primer is
complementary to the terminal coding region of the gene followed by
a BamHI restriction site (underlined). The ampliﬁed fragment was
puriﬁed and ligated in the pGEM-T Easy vector (Promega). After
checking the sequence, the gene was liberated from the plasmid by
digestion with HindIII and BamHI and ligated in a trypanosome-
speciﬁc expression vector containing already the GFP gene, pGC1,
derived from plasmid pHD1336 [44].
Induction of expression in bloodstream and procyclic cells was
done by addition of 1 or 5 μg·mL−1 Tet, respectively. Cells for
immunoﬂuorescence analysis were grown overnight, ﬁxed with 4%
formaldehyde in PBS, permeabilized with 1% Triton X-100 and spread
on poly-L-lysine coated slides. The slides were then incubated for
45 min in PBS containing 5% BSA, followed by incubation in PBS with
2% BSA and the primary antiserum (i.e. rabbit polyclonal anti-T. brucei
ALD as glycosomal marker). After washing with PBS, cells were
allowed to react with 5 mg·mL−1 Alexa 568 anti-rabbit IgG conjugate
(Molecular Probes), washed again and mounted in Mowiol. Cells were
visualized using a Zeiss Axiovert microscope coupled to an MRC-1024
confocal scanning laser imaging system (BioRad).
2.6. Construction of an expression system for recombinant protein and
antiserum production
A truncated version of the T. brucei 427 PEX13 gene (528 bp from
position 649 to the stop codon at 1176, comprising the region coding
for the 2nd putative transmembrane segment – encoded by the region
855 to 918 – and the SH3 domain) was ampliﬁed by PCR using Pfu DNA
polymerase (Fermentas) and the following set of oligonucleotides: 5′-
ATGGATCCGGCAAAAGCCGCGGAATTAGC-3′ (forward) containing a
BamHI restriction site underlined and 5′-TAGCGGCCGCTA-
GAGTTTTGTCTCCCTC-3′ (reverse) containing the stop codon and a
NotI site underlined. PCR product was puriﬁed, cloned using the
pGEM-T Easy and, after checking the sequence, excised from the
recombinant plasmid by digestionwith BamHI and NotI and ligated to
expression plasmid pACYCDuet-1 (Novagen) digested with the same
enzymes. The plasmid directs the synthesis of the recombinant
protein with an N-terminal extension of 14 residues including six
histidines [(His)6-tag]. E. coli strain BL21(DE3) cells were transformed
with this construct and used for bacterial expression of recombinant
protein TbPEX13-SH3.
Cells harbouring the recombinant PEX13-SH3 plasmid were grown
in 100 mL LB medium [63], supplemented with 25 μg·mL−1
chloramphenicol at 28 °C. Once the culture had reached an OD600 nm
of 0.5–0.6, isopropyl β-D-thiogalactanopyranosidewas added to a ﬁnal
concentration of 1 mM to induce the expression of the recombinant
protein and growth was continued for 16 h. Cells were harvested by
centrifugation (10,000 ×g, 15 min), resuspended in 30 mL of cell lysis
buffer containing 50 mM Tris/HCl, pH 8.0 and a complete protease
inhibitor cocktail (Roche Applied Science). Cells were disrupted by
three passages through a SLM-Aminco French pressure cell (SLM
Instruments, Inc.) at 6.9 MPa. Nucleic acids were degraded by
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4 °C. Cell debris and insoluble material were then spun down
(10,000 ×g, 30 min). The recombinant protein TbPEX13-SH3 was
completely insoluble (in inclusion bodies) and its further puriﬁcation
was performed by resuspending the pellet in 20 mL lysis buffer to
which 1% sodium deoxycholate and 1% CHAPS were added. After
stirring the suspension during 30 min at 4 °C, it was centrifuged at
12,000 ×g for 10min. This stepwas repeated three times but no CHAPS
was added at the last one. The pellet was then washed with the lysis
buffer containing 0.25% sodium deoxycholate and ﬁnally with a buffer
composed of 20 mM Tris pH 8.0 and 0.1 M NaCl. The pellet was then
resuspended in 3 mL lysis buffer containing 8 M urea and mixed
during 16 h at room temperature. When the total inclusion body mass
was solubilized, the solution was centrifuged at 15,000 ×g at 4 °C
during 10 min. The presence of the PEX13 in the different washes of
the inclusion bodies was checked by SDS/PAGE followed by Coomassie
Blue staining. As a large amount of the protein was already present in
the two ﬁrst washing steps of this protocol, the supernatant of the ﬁrst
wash was used for its puriﬁcation. To that end, the sample was
threefold diluted in lysis buffer, mixed with 1 mL HisLink Protein
Puriﬁcation Resin suspension (Promega) and incubated for 1 h at
room temperature. The resin with bound protein was poured into a
column, washed with 15 column volumes of lysis buffer containing
0.2 M NaCl and 0.2% CHAPS followed by elution of the protein using
three column volumes of the same buffer containing 500 mM
imidazole. Purity was checked by SDS/PAGE followed by Coomassie
Blue staining. The puriﬁed TbPEX13-SH3was used to raise a polyclonal
antiserum in a rabbit (Eurogentec).2.7. RNA interference
The T. brucei speciﬁc vector pHD677 [42] was used to generate
stable bloodstream and procyclic cell lines for the Tet-inducible
expression of double-stranded RNA of PEX13. Double-stranded RNA
was produced as hairpin molecule by transcription of a construct
comprising two similar fragments of the coding region of the gene, but
one 48 bp longer than the other, arranged as a direct inverted repeat.
This construct was prepared by ampliﬁcation of two PEX13 gene
fragments (1014 bp long for the sense fragment and 966 bp for the
antisense one), using the following primers: for the ampliﬁcation in
the sense orientation the forward primer 5′-ATAAGCTTGTT-
TATGGTGGCCTTGGTGG-3′ (HindIII site underlined) and reverse
primer 5′-TCTCGAGCCTCTCCAGAAGACGCAAAAA-3′ (XhoI site under-
lined), for the antisense region, the forward primer 5′-TCCGCTCGAG-
CAATTTCTTGTCATCAGTTGC-3′ (XhoI site underlined) and reverse
primer 5′-AAAGGATCCGTTTATGGTGGCCTTGGTG-3′ (BamHI site
underlined). The PEX13 sense–antisense construct was ﬁrst built
from the two PCR fragments by ligation in plasmid pTZ57R
(Fermentas) and cloned in E. coli. The proper composition and
sequence of the insert were checked, before it was transferred to
vector pHD677, downstream of the Tet-inducible PARP promoter.
Linearized recombinant pHD677-RNAi plasmid was targeted for
integration by homologous recombination into the transcriptionally
silent ribosomal RNA gene repeat spacer of the T. brucei genome.
Transfections of both forms of trypanosomes, and selection of clones
were performed as described above.
For induction of double-stranded RNA, cells were cultured in
appropriate medium [42] containing 1 µg·mL−1 of Tet for blood-
stream-form and 5 μg·mL−1 of Tet for procyclic-form cells. Cultures
were diluted daily to 2·105 cells ·mL−1 for bloodstream-form trypano-
somes or 1·106 cells ·39 mL−1 for procyclic trypanosomes. Cell den-
sities were determined using a cell counting grid (Bürker-Türk, with a
depth of 0.01 mm for procyclic-form and 0.1 mm for bloodstream-
form cells) and growth curves were plotted as the product of cell
density and total dilution versus time.Relocation of glycosomal enzymes upon RNAi induction was
studied by subcellular fractionation of cells upon their treatment
with various concentrations of digitonin, following the procedure
described by Galland et al. [11] followed by western blot analysis of
enzymes released from the cells (see Section 2.3). Localization of
enzymes in cell compartments was also performed by immunoﬂuor-
escence studies. Wild-type bloodstream and procyclic cells and
trypanosomes not-induced or induced for RNAi against PEX13 (24 h
and 40 h for bloodstream and 48 h for procyclic cells) were prepared
as described above. Cells were then incubated with the primary
antiserum (mouse monoclonal anti-T. brucei TIM at 1:5000 dilution
and rabbit polyclonal anti-T. brucei ALD or GAPDH at 1:5000 and
1:1500 dilution, respectively). Cells were washed in PBS and then
allowed to react with ﬂuorescein-conjugated secondary antibody
(1:800 Alexa ﬂuor 488 anti-mouse IgG or 1:800 Alexa 568 anti-rabbit
IgG). After a last washing step, cells were mounted in Mowiol and
visualized as described above.
2.8. Yeast two-hybrid analyses
Yeast two-hybrid plasmids encoding GAL4BD or GAL4AD fused to
fragments encoding T. brucei full-length PEX13, PEX13-TM2+SH3
(267–392), PEX5_WY1 (47–107), PEX5_WY2 (177–284), PEX5_WY3
(312–335), full-length PEX7 and full-length PEX14 were prepared by
ampliﬁcation of the corresponding sequences with oligonucleotides
adding EcoRI and BamHI restriction sites. Ampliﬁed DNA fragments
were inserted into the pGAD424 and pGBT9 vectors (Clontech). Yeast
two-hybrid analyses in strains SFY526 or HF7c were performed as
described by Fransen et al. [64]. Double transformants were selected
on SD synthetic medium without tryptophan and leucine. Histidine
auxotrophy of transformed HF7c was determined by growth on
selective plates lacking leucine, tryptophan and histidine but contain-
ing 5 mM 3-aminotriazole.
3. Results
3.1. Identiﬁcation and sequence analysis of the T. brucei PEX13
homologue
Previously, PEX13 has been identiﬁed by genetic means in yeasts
and mammalian cells. The amino acid sequence of PEX13 is in general
poorly conserved, but the domain organization is retained [28].
Attempts to identify a candidate PEX13 in the trypanosomatid genome
databases (http://www.genedb.org/) by (PSI-)BLAST homology
searches using yeast or mammalian sequences as queries failed.
Recently, PEX13 has also been identiﬁed by genetic studies in Arabi-
dopsis thaliana, but it appeared to be very different from its
homologues in other organisms [36]. As for other PEX13s, it possesses
two putative transmembrane regions, but only a divergent, tentative
SH3 domain was reported. No trypanosomatid homologue was found
either by BLAST searches with this plant PEX13 sequence.
Alternative search strategies were then considered, in order to
take advantage of common features of PEX13 proteins. The SH3
domain is typically considered as common to PEX13 sequences
[28,36]. However, our own analyses failed to reveal any sign of an
SH3 domain in the A. thaliana PEX13 protein; SH3 proteins were not
among the hits, even borderline, of proﬁle–proﬁle matching [49] or
fold recognition [50] methods. Furthermore, a secondary structure
prediction for the tentatively identiﬁed SH3 domain of A. thaliana
PEX13 produced only two short α-helices, in sharp contrast to the
all-β fold adopted by SH3 domains.
We then searched the Leishmania major genome with the PPKPWE
sequence found, with few variations, within 10 residues of the N-
terminus in yeast, mammalian and plant PEX13 sequences. This
sequence is not present in any predicted L. major protein. A simpler
Fig. 1. Alignment of PEX13 amino-acid sequences. Alignment of the PEX13 sequences of the three trypanosomatids, T. brucei, T. cruzi and L. major. The YGxmotifs (where X is N, G, S, T
or A) and PTS1 are shown as white on grey at the N– and C–termini, respectively. The SH3 domain is boxed and the consensus predicted PEX19 interaction site [66] is indicated by a
bar underneath the alignment. Shading indicates the degree of sequence conservation between the sequences. Accession numbers of sequences used in the alignment are:
Tb10.61.1950, Tc00.104705351187.124 and LmjF19.0070. The sequences were aligned with MUSCLE [57] and the ﬁgure was produced with Jalview [58].
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positioned near the N-terminus.
Instead we focused on the multiple conserved YG motifs followed
by small hydrophilic residues (GSTNA) that are found in all
experimentally identiﬁed PEX13 sequences. A pattern consisting of
three such motifs, separated by 1–15 residues, was used to search the
L. major genome, revealing eight matches. Some of these could be
eliminated since they strongly matched domains incompatible with
PEX13 function such as dynein and RNA helicases. One of the
remaining matches, LmjF19.0070, contained an SH3 domain posi-
tioned, as in mammalian and yeast PEX13 sequences, towards the C-
terminus. In fact, the L. major genome appears to contain only ﬁve
proteins that contain SH3 domains. One of these strongly resembles a
paraﬂagellar rod protein while in none of the remaining three is the
SH3 positioned at the C-terminus. These considerations reinforced the
status of LmjF19.0070 as most favoured candidate. Various programs
(see Section 2.2) were then used to search for predicted transmem-
brane helices in LmjF19.0070. These produced predictions of between
two and four transmembrane helices, but suggested that LmjF19.0070
was indeed a transmembrane protein, as expected of PEX13
sequences. Putatively orthologous proteins to LmjF19.0070, with
similar predicted properties and domains, could readily be found in
the T. brucei and T. cruzi genomes (locus identiﬁers Tb10.61.1950 and
Tc00.1047053511287.124, respectively). Most interestingly, the C-
terminal SH3 domain terminates, in each of the three trypanosomatid
sequences, with the tripeptide –TKL, a sequence reminiscent to a PTS1Fig. 2. PEX13 is associated with structures in the cell corresponding to glycosomes. Procyclic c
repressor. Cells are induced for GFP–PEX13 expression for 4 h (top panels) or overnight (bot(Fig. 1). In contrast, no PTS1-like motifs have been found in PEX13s of
other organisms. Predictions of transmembrane helices for the T.
brucei protein again vary but the residue ranges from 210 to 240 and
285 to 306 appear in multiple predictions.
Insertion of most (i.e. class I) peroxisomal membrane proteins
(PMPs) into the membrane involves the action of the chaperone
PEX19 [65]. A strong potential PEX19-binding site could be identiﬁed
in the three candidate trypanosomatid PEX13s (Fig. 1) by an algorithm
developed [66] to identify such sites in yeast PMPs and previously
shown to be valid also for T. brucei glycosomal PMPs [44,67]. The
sequences of the three trypanosomatid candidate PEX13 species are
only 30–50% identical to each other, and similarity drops to 7–18%
overall identity with those of non-kinetoplastid PEX13s.
3.2. The putative T. brucei PEX13 is a glycosomal membrane protein
The intracellular localization of the protein Tb10.61.1950, the
putative PEX13, was ﬁrst investigated by confocal immunoﬂuores-
cence microscopy using Green Fluorescent Protein (GFP) fusion
constructs. Bloodstream and procyclic form cell lines were created
each stably transformed with a construct for inducible expression of
the candidate PEX13 protein fused to the C-terminus of GFP. In both
cell lines, a punctuate pattern was observed (Fig. 2). This pattern was
superimposable with the one observed by immunoﬂuorescence for
the glycosomal enzyme aldolase (ALD), implying that the new protein
is indeed associated with glycosomes.ells are shown expressing PEX13 fused to the C-terminus of GFP under control of the Tet
tom panels). Aldolase is shown in red and ﬂuorescence associated with GFP is in green.
Fig. 3. Localization of PEX13 in T. brucei by western blot analysis of cell fractions. Proteins in similar volumes of subcellular fractions from respectively procyclic (panel A) and
bloodstream (panel B) form parasites, prepared as described in the Materials and methods section, were size-fractionated by SDS/PAGE, blotted and probed with antisera raised
against the C-terminal half of T. brucei PEX13, PEX11, ALD, TIM, glycosomal GAPDH, ENO and PYK. Lane 1, cellular extract; lane 2, cytosol; lane 3, nuclear fraction; lane 4, large granular
fraction; lane 5, small granular fraction; lane 6, microsomal fraction. The intensity of the signals in lane 1 may not be related to that of the signals in other lanes because the large
amount of protein in the sample loaded in lane 1 and the non-linearity between protein and signal at such high concentrations in the visualization system used. 100 μg and 25 μg of
the small granular samples obtained from procyclic (panel C, lanes 1 and 2) and bloodstream (panel C, lanes 3 and 4) cells, respectively, were treatedwith digitonin as described in the
Materials and methods section to prepare membrane and soluble extracts. Blots with proteins from the membrane extracts (lanes 1 and 3) as well as the soluble proteins from the
small granular fractions (lanes 2 and 4) were probed with T. brucei PEX13 and PEX11 antisera.
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blots prepared from subcellular fractions, a polyclonal antiserum was
raised in a rabbit against the bacterially expressed, puriﬁed C-terminal
half of the protein (see Section 2.6). A differential centrifugation was
performed on lysates from both procyclic-form (Fig. 3A) and blood-
stream-form (Fig. 3B) wild-type cells. Proteins of the cellular extract,
cytosolic, nuclear, large granular (mitochondria enriched), small
granular (glycosomes enriched) and microsomal fractions were size-
fractionated by SDS/PAGE, blotted and probed with the anti-PEX13
antiserum as well as antisera speciﬁc for the following controls: the
glycosomal membrane protein PEX11, the glycosomal matrix proteins
ALD, triosephosphate isomerase (TIM) and glyceraldehyde-phosphate
dehydrogenase (GAPDH), and the cytosolic enzymes enolase (ENO)
and pyruvate kinase (PYK) (Fig. 3A and B). The major part of PEX13
sedimented in the large and small granular fractions and microsomes
together with the glycosomal membrane and soluble control proteins,
and different from the cytosolic controls ENO and PYK, although a
small amount of these latter proteins could be also detected in all
other fractions, as common with this fractionation method [59,60]. A
more quantitative analysis of the data from this experiment is
available as Supplementary Material (text and Fig. S1 and S2).Fig. 4. Effect of RNAi-dependent depletion of PEX13 on the growth of bloodstream-form (left
(■) cells or cells transfected with a construct expressing double-stranded RNA correspondin
(♦) of tetracycline, the inducer of double-stranded RNA expression. Results of counting areFurthermore, to determine if the PEX13 candidate is indeed
associated with membranes, as inferred from the predicted
presence of transmembrane helices, a glycosomal membrane extract
prepared from both trypanosome cell types was analyzed (Fig. 3C).
A protein with an apparent mass at SDS/PAGE between 45 and
50 kDa was detected with the anti-PEX13 antiserum in the fractions
corresponding to the membrane extract in which also PEX11 was
located. These results conﬁrm that the putative PEX13 is localized in
the glycosomal membrane.
3.3. PEX13 is essential for bloodstream and procyclic trypanosomes
In all organisms where it has been identiﬁed so far, PEX13 was
shown to be essential for both PTS1 and PTS2-mediated import of
proteins into peroxisomes. Under peroxisome-speciﬁc selective
conditions, the peroxin appeared to be also essential for growth
[68–70]. In order to assess if the putative PEX13 plays also such an
essential role in trypanosomes, we ﬁrst determined if a decrease in the
PEX13 protein level caused by RNAi affected the growth rate of
cultured cells corresponding to each of the life-cycle stages of the
parasite. A construct expressing double-stranded RNA correspondingpanel) and procyclic-form (right panel) trypanosomes. The growth proﬁles of wild-type
g to PEX13 mRNAwere determined for cells growing in the absence (X) or the presence
shown as the log10 values of cumulative cell numbers.
Fig. 5. RNAi-induced depletion of PEX13 from T. brucei cells as determined by western
blot analysis. 60 μg of a total membrane protein extract from procyclic trypanosomes
(A) and 100 μg of a total protein extract from bloodstream-form trypanosomes (B) were
loaded into each of the lanes of the gel. The lane labelled WTcontained a lysate of wild-
type cells; the lanes −Tet non-induced cells and +Tet cells induced for 48 h (procyclic
forms) or 24 h (bloodstream forms). Western blot analysis was performed as described
in Materials andmethods with the antisera of the controls TbGAT3 and enolase (TbENO)
used at dilutions of 1:10,000 and 1:100,000, respectively.
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2.7. The linearized plasmid, which also contained a gene for
constitutive expression of a hygromycin-resistance marker, was used
to transfect both bloodstream and procyclic cell lines; it was stably
integrated into a transcriptionally silent region of the genome. RNAi
was induced by addition of tetracycline (Tet) to the cultures, resulting
within 24 h in reduced growth of bloodstream cells; the parasites
started to die after 48 h. In procyclics, the effect of RNAi on growthwas
less severe; no effect was observed during the ﬁrst 48 h after
induction. Cell death occurred during the following four days when
the density of the culture decreased gradually (Fig. 4).Fig. 6. Effect of PEX13–RNAi on the subcellular distribution of glycolytic enzymes analyz
trypanosomes were incubated for 4 min with increasing concentrations of digitonin indicate
cells was assayed after centrifugation of treated cell suspensions and preparation of west
induction of RNAi. (B) Procyclic trypanosomes induced 48 h for PEX13-RNAi. Shown is the
noninduced (−Tet) cells and trypanosomes in which RNAi was induced by the addition of te
X-100 to dissolve all membranes.The decrease in the PEX13 level upon induction of the RNAi was
conﬁrmed by western blot analysis of total membrane protein
extracted from procyclic and total protein extracted from bloodstream
trypanosomes, comparing wild-type cells with cells containing the
RNAi construct that were either non-induced or induced for 48 h.
Non-induced cells contain less PEX13 than wild-type cells, probably
due to a transcription leakage through the promoter. The induced cells
are virtually devoid of the peroxin. The levels of GAT3, an ABC-
transporter in the glycosomal membrane [44], and ENO, used as
controls, remained unaffected (Fig. 5).
3.4. PEX13 is involved in the glycosome biogenesis
The bloodstream and procyclic form RNAi cell lines were used to
investigate the role of PEX13 in the import of glycosomal matrix
proteins. Bloodstream-form cells 24 h after induction of RNAi for
PEX13 and procyclic-form cells 48 h after induction, when growth is
already compromised but before parasites started to die, were used
for analysis of protein import. Localization of proteins in different
subcellular compartments was studied by treating cells with
increasing concentrations of digitonin, a detergent that permeabilizes
membranes by forming insoluble complexes with sterols present in
the membranes. As the sterol content is different in plasma
membrane, glycosomal and mitochondrial membranes, these mem-
branes are differentially permeabilized depending of the digitonin
concentration. At low digitonin concentrations, only the plasma
membrane is disturbed leading to release of merely cytosolic
proteins. When the concentration is increased, the glycosomal
membrane and subsequently the mitochondrial membrane are
rendered permeable, causing also the release of the contents of
these organelles from the cell.
Release of enzymes from cells was assayed bywestern blot analysis
of proteins in the supernatants after centrifugation of the cultures (Fig.
6). For wild-type and non-induced bloodstream and procyclic-form
trypanosomes, low concentrations [between 0.01 and 0.25 mg·(mg
protein)−1] of digitonin only released the cytosolic markers PYK and
ENO (not shown) from cells, whereas the glycosomal enzymes
GAPDH, TIM and glycerol kinase (GK) remained in the cell; detergented by digitonin-dependent cell fractionation. Intact bloodstream and procyclic-form
d as described in Materials and methods. Release of PYK, GK, GAPDH, ALD and TIM from
ern blots of the supernatants. (A) PEX13-depleted bloodstream-form cells 24 h after
release of enzyme from wild-type (WT) trypanosomes not having the RNAi construct,
tracyclin (+Tet). Total release (T.R.) lanes correspond to cells incubated with 0.5% Triton
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from the organelles. In bloodstream-form trypanosomes induced for
24 h and 40 h, the subcellular localization of the PTS1 and PTS2
proteins GAPDH and ALD respectively, is affected (Fig. 6A). Part of
these proteins, particularly important in the case of ALD, is released
from the cells already at 0.1 mg digitonin·(mg protein)−1, a
concentration at which the glycosomal membrane should still be
intact, indicating that this fraction of the GAPDH and ALD has not been
imported into glycosomes but remained cytosolic in these cells. In
contrast, the I-PTS protein TIM remains localized in the glycosome, as
does the PTS1 protein GK; the differential digitonin concentration-
dependent release of different glycosomal proteins is further
addressed in the Discussion. For procyclic-form trypanosomes
induced for 48 h (Fig. 6B), a cytosolic localization was observed for a
large part of GAPDH and GK (PTS1 proteins), ALD (PTS2) and TIM (an I-
PTS protein).
To conﬁrm the results obtained by the digitonin titration, we also
compared the subcellular distribution of glycosomal enzymes inwild-
type and RNAi cell lines by immunoﬂuorescence studies (Figs. 7 and
8). In wild-type and non-induced bloodstream-form cells, GAPDH,
ALD and TIM each showed a punctuate pattern typical of a glycosomal
localization (Fig. 7). In cells induced for 24 h (not shown) or 40 h, the
ﬂuorescence associated with TIM still showed a punctuate pattern;
there was no (or only little) ﬂuorescence in the cytosol. However, the
pattern seemed to be different for ALD and GAPDH, with the
ﬂuorescence being largely spread over the entire cytosol but with
some puncta still visible (Fig. 7, panels 1C and 2C, upper row).
Similarly, inwild-type and uninduced procyclic cells, GAPDH, ALD and
TIM gave a punctuate pattern characteristic of glycosomal enzymes,
although in many cells also a faint ﬂuorescence signal was found for
ALD in the cytosol in uninduced cells, probably reﬂecting some
leakiness of the inducible promoter of the RNAi construct (Fig. 8). In
cells where the RNAi was induced for 48 h, a large amount of GAPDH,Fig. 7. Effect of PEX13-RNAi on the subcellular distribution of glycolytic enzymes determine
(1–2B) trypanosomes non-induced for RNAi against PEX13; (1–2C) trypanosomes induced
DNA in blue.ALD and to a lesser extent of TIM was mislocalized to the cytosol, but
part of each of these enzymes was also still associated with
glycosomes (Fig. 8, panels 1C and 2C, upper row).
It should be noted that both the bloodstream-form (Fig. 7) and
procyclic induced cultures (Fig. 8) showed heterogeneity with regard
to the ﬂuorescence pattern: whereas in most cells considerable
ﬂuorescencewas found in the cytosol (panels C, upper row), in a lower
percentage of cells no or only little cytosolic ﬂuorescence was
observed (panels C, lower row) thus showing little difference with
the wild-type or uninduced cells (panels A and B, respectively).
The fact that RNAi induction led to partial mislocalization of
glycosomal proteins in both bloodstream and procyclic-form trypano-
somes clearly demonstrated the involvement of the attacked protein
in the targeting of newly synthesized proteins to the matrix of the
glycosomes and thus provided evidence for its identity as an authentic
PEX13. The fact that mislocalization is only partial may be due to an
incomplete knockdown of PEX13 (see Fig. 5). Even more importantly,
however, is the likelihood that PEX13 knockdown only affects the
localization of newly synthesized proteins that cannot be (efﬁciently)
imported anymore into the organelles; protein already imported
before induction of RNAi or the protein inside mature glycosomes that
would not be import competent anymore will not be relocated. It is
unlikely that trypanosomes with a drastic mislocalization of glycoso-
mal enzymes can be detected because previous experiments have
shown that such mislocalization is highly detrimental for trypano-
somes which heavily rely on the glycosomally located process of
glycolysis [7–11,15,71,72].
3.5. PEX13 is a component of the docking complex and interacts with
PEX5 and PEX14
In order to investigate further the role of PEX13 in glycosome
biogenesis in trypanosomes and to compare it with that of itsd by immunoﬂurescence microscopy in bloodstream parasites. (1–2A) Wild-type cells;
for 40 h for RNAi against PEX13. ALD and GAPDH are labelled in red, TIM in green and
Fig. 8. Effect of PEX13-RNAi on the subcellular distribution of glycolytic enzymes determined by immunoﬂuorescence microscopy in procyclic cells. (1–2A) Wild-type cells; (1–2B)
trypanosomes non-induced for RNAi against PEX13; (1–2C) trypanosomes induced during 48 h for RNAi against PEX13. ALD and GAPDH are labelled in red and TIM in green.
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performed preliminary studies of its interaction with other peroxins
using the yeast two-hybrid system. These experiments also aimed to
deﬁne which parts of the different peroxins are involved in
interactions. To this end, different constructs of T. brucei PEX13,
PEX5, PEX7 and PEX14 were prepared as described in Section 2.8 and
assayed for interactions by yeast two-hybrid screens. Concerning a
potential interaction of PEX13 with the PTS1 receptor PEX5, we were
unable to use constructs coding for large parts of PEX5 because theyFig. 9. PEX13 interacts with PEX14 and PEX5. Two-hybrid interactions between PEX13 and PE
β-galactosidase activity and a test for His auxotrophy in yeast strains SFY526 and HF7c, res
activationwhen fused to the DNA-binding domain of GAL4 (not shown). Two representative
or white mean that the proteins were able to interact or not, respectively, in the β-galactoscaused auto-activation in the two-hybrid assay. However, constructs
limited to some small parts of PEX5 could be used. Studies with PEX5
and PEX13 of other organisms had already shown that some of the
multiple speciﬁc pentapeptide motifs (WXXXF/Y) present in the N-
terminal half of PEX5 mediate interactionwith PEX13, whereas others
are responsible for interaction with PEX14 (reviewed in [15,28]). T.
brucei PEX5 possesses three such motifs [73,74]. Using ﬂuorescent
peptides corresponding to each of these motifs it was shown that
motifs 1 and 3 interacted with the N-terminal half of PEX14, whereasX14, PEX7 or one of the pentapeptidemotifs of PEX5 weremonitored by a ﬁlter assay for
pectively. A PEX13–PEX7 interaction could not be demonstrated as PEX7 causes auto-
independent transformants are shown in the His-auxotrophy assay. The indications blue
idase assay.
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shortened constructs of the N-terminal half of PEX5 showed that full-
length PEX13 is able to interact with a construct only containing the
third pentapeptide motif of PEX5 (PEX5_WY3), whereas no interac-
tions could be seenwith the constructs expressing only the ﬁrst or the
second motif (PEX5_WY1 and PEX5_WY2, respectively) (Fig. 9).
Similar results were obtained with the C-terminal half of PEX13,
comprising the second predicted transmembrane segment and the
SH3 domain (not shown). The interaction between the PEX13 and
PEX14 was also assayed with the two-hybrid system and conﬁrmed:
full-length PEX13 (Fig. 9) as well as the C-terminal-half PEX13
construct (not shown) displayed interaction with full-length PEX14.
The interaction with PEX7 was also tested. However auto-activation
by this PTS2-receptor fused to the DNA-binding domain of GAL4
prevented the determination of whether PEX13 interacted directly
with PEX7. These results together conﬁrm T. brucei PEX13 as a
component of the docking complex formatrix protein import, because
this glycosomal membrane peroxin is able to interact with the other
component of the complex, PEX14, as well as with the PTS1-protein
receptor PEX5.4. Discussion
Previously, various peroxins could be identiﬁed in the trypanoso-
matid databases by homology searches using yeast or mammalian
sequences as queries, despite the generally low level of conservation
(around 15–35% identity) [15]. These include the receptors of the PTS1
and PTS2 proteins, PEX5 and PEX7, and a component of the docking
complex, PEX14. However, all attempts to ﬁnd by homology searches a
candidate for the other component of the docking complex, PEX13, or
by PCR ampliﬁcation with primers designed based on conserved
sequence motifs remained unsuccessful. Furthermore, we were
unable to identify a PEX13 upon puriﬁcation of protein complexes
from glycosomal membranes using TAP-tagged PEX5 and PEX14.
Several reasons could be invoked which together might explain this
failure. First, interactions between PEX13 and PEX5 or PEX14 are
transient with afﬁnities that are dependent onwhether PEX5 is loaded
with a PTS1 protein, as has been shown for the P. pastoris PEX5–
PEX13-SH3 and PEX5–PEX14 interactions [75] and for the L. donovani
PEX5–PEX14 interaction [76]. The afﬁnity of PEX13 for the baits may
be too low and/or the interaction does not resist the laborious
puriﬁcation procedurewhich also involves a treatment with detergent
to solubilize protein complexes from membranes. Moreover, puriﬁca-
tion of the TAP-tagged protein complex could only be achieved with
very low yield due to the facts that the membrane of the small
glycosomes represents only a small fraction of the total membrane of a
trypanosome and in general the abundance of proteins, including
PEX13, in peroxisomal membranes is very low.
Publication of the sequence of A. thaliana PEX13 [36] and its
comparison with other PEX13s revealed, by a novel bioinformatics
approach described in Section 3.1, some patterns that led to the
identiﬁcation of the trypanosomatid PEX13 despite the very low level
of sequence conservation (7 to 18% overall identity) and the absence of
characteristics present in other PEX13s. The identiﬁcation of T. brucei
PEX13 provides an opportunity to reassess shared features of widely
divergent PEX13 proteins from four distinct groups — fungi, animals
(including human, C. elegans, Xenopus tropicalis and Drosophila
melanogaster), plants and trypanosomatids. BLAST databases searches
are capable of demonstrating homology between the fungal and
animal groups, but no other pairwise relationships among the four
groups are evident by this standard methodology. SH3 domains are
found in all groups except the plant proteins (see Section 3.1) and a
PPKPWE motif (or near variant of it) is found near the N-terminus of
all groups except the trypanosomatids. However, sequence alignment
(although the complete set of PEX13 proteins are unlikely to behomologous throughout their length) reveals that the only universal
deﬁning characteristic of all these PEX13s is a Gly-rich region of low
sequence complexity. This contains the YGx repeats (x being G, A, S, T
or N) used in our search for the trypanosomatid PEX13 sequences, but
also contains less common variations on this such as YS, FG and FS.
This region is positioned close to or at the N-terminus in trypanoso-
matid sequences but is preceded by around 70 residues in the other
groups. The length of the Gly-rich region also varies between groups:
the PEX13 sequences from S. cerevisiae, human, T. brucei and A.
thaliana have lengths of approximately 70, 30, 100 and 80 residues,
respectively. The function of this common region is completely
obscure: low complexity regions with strong sequence bias are
relatively common in the database but ill understood. Some kinds of
small sequence repeats have been characterized, but these exhibit
much greater regularity and speciﬁc structural roles (e.g. [77,78]).
Essentially no regular secondary structure is predicted for any of these
PEX13 regions, yet they are not predicted to be intrinsically disordered
[79] despite the relevant functional correlations of intrinsically
disordered proteins— protein–protein interactions and cell regulatory
processes among them. Very recently, the FG motifs of nucleoporins,
components of the nuclear pore complex allowing trafﬁc between
nucleus and cytosol, have been characterized [80]. There is an
interesting functional similarity between these proteins and PEX13s,
among which YG motifs appear to be an important deﬁning
characteristic. In nucleoporins the motifs are proposed to act as
‘cohesion motifs’ imparting order, through protein–protein interac-
tions, either intra- or inter-molecularly [80]. Despite the fact that the
PEX13 proteins are not predicted to be intrinsically disordered, while
the nucleoporins clearly are, it may be that the PEX13 YG motifs play a
role in protein–protein interactions.
In common with all other PEX13s, each of the trypanosomatid
sequences has predicted transmembrane segments, probably two
although the number depends on the software used, and a putative
PEX19-binding site. Two membrane segments would result in a
topology of the protein consistent with that proposed for other
PEX13s: the N- and C-terminal regions exposed to the cytosol and a
loop in the matrix of the organelle [28,40]. Most surprising, however,
was the ﬁnding of a variant of a PTS1 motif at the C-terminus of the
protein, fully conserved in the three trypanosomatid PEX13 homo-
logues but not present in the PEX13 of any other eukaryote studied so
far. The presence of this PTS1-like sequence raises a number of
questions. The conservation throughout the estimated hundreds of
million of years of trypanosomatid evolution suggests an important
function. However, it is unlikely that the motif is involved in
glycosome-targeting of PEX13 in trypanosomatids, because this
peroxin is a transmembrane protein so its routing is expected not to
depend on PTS1 or PTS2, motifs characteristic for matrix proteins, but
instead on a peroxisomal membrane-targeting speciﬁc mPTS. This
latter motif generally comprises several positively charged residues
near a transmembrane domain [81] as we previously also showed to
be functional for T. brucei glycosomal membrane proteins [44].
One could hypothesize that the C-terminal PTS1-like sequence is
involved in the detachment of PTS1-proteins from PEX5 upon or
during translocation, as proposed for the PTS1-bearing PEX8 in
yeasts [17]. No PEX8 has so far been identiﬁed in trypanosomes. Like
a PEX8, the Trypanosoma PEX13 has also an internal sequence
(residues 148–156) which conforms to the PTS2 motif described by
Petriv et al. [82] and that has been hypothesized to separate PTS2
proteins from PEX7. However, such a function might require that the
PTS1 and PTS2 sequences of PEX13 are present in the matrix of
glycosomes; indeed yeast PEX8 is associated with the matrix face of
the peroxisomal membrane. But the C-terminus of PEX13, including
the SH3 domain, is usually considered to be in the cytosol [28,40]. It
seems therefore most likely that the SH3 domain of trypanosomatid
PEX13, along with the adjacent PTS1-like sequence, is exposed to the
cytosol. Similarly, the PTS2-like motif is just upstream of the ﬁrst
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cytosol. Future research should address the function of the PTS1-like
motif in trypanosomatid PEX13.
In this paper, we also showed that the T. brucei PEX13 is
functionally similar to its counterparts in other eukaryotes, despite
the low degree of structural identity it shares with them. RNAi
experiments showed the essential function of PEX13 in trypanosomes
as the parasites die within 48 h after inducing the degradation of its
mRNA. The involvement of the protein in glycosome biogenesis and
especially in the import of matrix proteins was conﬁrmed by the
relocation of part of these proteins from the organellar matrix to the
cytosol when parasites were depleted of PEX13mRNA. Such relocation
was shown by cell fractionation using selective membrane permea-
bilization with digitonin: in procyclic cells part of the ALD (PTS2),
GAPDH (PTS1) and TIM (I-PTS) becamemislocalized in the cytosol and
in bloodstream forms the same was observed for ALD and GAPDH, but
TIM and GK, another PTS1 protein, remained in the glycosome. The
observation that the extent of relocation, as a function of the digitonin
concentration, is different for the various glycosomal enzymes, even
those with a similar PTS motifs, has also been made with RNAi
mutants of other peroxins such as PEX14 [72]. In that case too,
relocation of GK to the cytosol was less than for some other enzymes.
The results obtained by immunoﬂuorescence studies with procyclic
and bloodstream cells induced for 48 h and 24 h (not shown) or 40 h,
respectively, are in accordance with those of the digitonin/western
blot experiments.
These results with the PEX13 RNAi cell lines indicate that PEX13, as
a component of the docking complex, is indeed involved in import of
PTS1, PTS2 and I-PTS proteins. The data obtained by yeast two-hybrid
experiments suggest that PEX13 is able to form a complex, at least
transiently, with PEX5 and PEX14. However we couldn't demonstrate
a direct interaction between PEX7 and PEX13 by the same technique
due to the auto-activation of the yeast system by PEX7. Previously we
have already provided strong indications for an interaction of T. brucei
PEX7 with PEX5 [11] and for the related trypanosomatid L. major a
PEX7–PEX14 interaction has also been established [83] in line with
observations in many other organisms.
For a full interpretation of the results obtained by RNAi it should be
realized that in both mammals and S. cerevisiae PEX13 has been
shown to be important for the correct localization of PEX14 to the
peroxisomal membrane. In the absence of PEX13, PEX14 is mis-
localized to other organellar membranes in the cell [41,84]. If this is
also the case in trypanosomes, mislocalization of matrix proteins to
the cytosol upon knocking down the expression of PEX13 might result
from the absence of PEX14, the already proved interacting partner of
PEX5 in the glycosomal membrane. This issue therefore requires
further investigation before a detailed model for import of matrix
proteins can be proposed.
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